CancerNCT07780903
A Study of a Digital Program for Helping Young Adult Cancer Survivors Learn About Financial Issues Related to Healthcare
An observational study of Cancer, run by Memorial Sloan Kettering Cancer Center at 1 site in United States.
Trial summary
The purpose of this study is to find out whether the Making Cents of Medical Costs (MCMC) program is acceptable, appropriate, accessible, and practical (feasible) for young adult cancer survivors. Read more about this study
- Who is it for?
- Ages 18 to 39 years
- Conditions the study is for
- Cancer
- What is being tested?
- Making Cents of Medical Costs
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 30 participants
- Where
- 1 siteUnited States
- Study dates
- 17 Aug 2026to 17 Aug 2028
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 39 years
- All sexes
- No healthy volunteers
- Adult
Study population: Young adult cancer survivors at Memorial Sloan Kettering Cancer Center
Who may be able to join
- English-speaking cancer survivors who are 18-39 years old
- Diagnosed with cancer after age 14
- Has access to an Internet-enabled device
- All disease sites and diagnosis are allowed; survivors must have completed active treatment
Who cannot join
- Received systemic therapy within the last 1 year
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York, 10065
Danielle Friedman, MD, 212-639-7376, FriedmaD@mskcc.org
Kenneth Offit, MD, 646-888-4050
About this study
Official title: Making Cents of Medical Costs: A Digital Financial Toxicity Intervention for Adolescent and Young Adult Cancer Survivors
The purpose of this study is to find out whether the Making Cents of Medical Costs (MCMC) program is acceptable, appropriate, accessible, and practical (feasible) for young adult cancer survivors.
- Conditions
- Cancer
- Being tested
- Making Cents of Medical Costs
- Keywords
- cancer, 26-316, Memorial Sloan Kettering Cancer Center
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Making Cents of Medical CostsBehavioural
Making Cents of Medical Costs (MCMC) is a three-session digital intervention to enhance cost-related health literacy, health insurance literacy, and financial capability.
| Study group | Role | What they receive |
|---|---|---|
| Young Adult Survivors | Young Adult/YA cancer survivors (18-39 years old) Receives: Behavioral: Making Cents of Medical Costs |
What is being measured
The primary outcome is the main question the study is designed to answer.
Mean overall scores of Making Cents of Medical Costs (MCMC)
Assess participant-reported acceptability, appropriateness, accessibility, and feasibility of the Making Cents of Medical Costs (MCMC) intervention in a sample of 30 survivors of Adolescents and Young Adults (AYA) cancer. Acceptability, appropriateness, and feasibility will be defined as mean overall scores ≥3 (agree) within each domain for at least 70% of respondents.
Measured: 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Aug 2026
- Study start17 Aug 2026
- Primary completion17 Aug 2028 (estimated)
- Study completion17 Aug 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CancerStudies of the same condition, open and under way.
- More trials run by Memorial Sloan Kettering Cancer CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Danielle Friedman, MD, Principal investigator, Memorial Sloan Kettering Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07780903
- Sponsor's protocol ID
- 26-316
- Status last verified
- Aug 2026
- First submitted
- 18 Aug 2026
- Last updated
- 24 Aug 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made following one year after publication and for up to 36 months later. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.
Study at a glance
From the registry record, last updated by the sponsor on 24 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Making Cents of Medical Costs: A Digital Financial Toxicity Intervention for Adolescent and Young Adult Cancer Survivors
- ClinicalTrials.gov ID
- NCT07780903
- Acronym / sponsor ID
- 26-316
- Conditions
- Cancer
- Keywords
- cancer, 26-316, Memorial Sloan Kettering Cancer Center
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Memorial Sloan Kettering Cancer CenterUniversity, hospital or other
- Study start
- 17 Aug 2026 (actual)
- Primary completion
- 17 Aug 2028 (estimated)
- Study completion
- 17 Aug 2028 (estimated)
- First posted
- 24 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to find out whether the Making Cents of Medical Costs (MCMC) program is acceptable, appropriate, accessible, and practical (feasible) for young adult cancer survivors.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Young Adult Survivors | – | Behavioral: Making Cents of Medical CostsYoung Adult/YA cancer survivors (18-39 years old) |
Who may qualify
- Ages
- 18 to 39 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- Young adult cancer survivors at Memorial Sloan Kettering Cancer Center
Key inclusion criteria (4 listed)
- English-speaking cancer survivors who are 18-39 years old
- Diagnosed with cancer after age 14
- Has access to an Internet-enabled device
- All disease sites and diagnosis are allowed; survivors must have completed active treatment
Key exclusion criteria (1 listed)
- Received systemic therapy within the last 1 year
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Making Cents of Medical CostsMaking Cents of Medical Costs (MCMC) is a three-session digital intervention to enhance cost-related health literacy, health insurance literacy, and financial capability. | Behavioural | Young Adult Survivors |
Primary outcome
Mean overall scores of Making Cents of Medical Costs (MCMC)
Time frame: 12 months
Assess participant-reported acceptability, appropriateness, accessibility, and feasibility of the Making Cents of Medical Costs (MCMC) intervention in a sample of 30 survivors of Adolescents and Young Adults (AYA) cancer. Acceptability, appropriateness, and feasibility will be defined as mean overall scores ≥3 (agree) within each domain for at least 70% of respondents.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Aug 2026.
- Memorial Sloan Kettering Cancer CenterLink provided by the sponsor.
- Individual participant dataSharing planned: Yes. Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made following one year after publication and for up to 36 months later. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.
Related trials for Cancer
RecruitingPhase 2
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Not yet recruiting
Effect of a Health Belief Model Based Digital Nudge Intervention on Breast Cancer Screening
Breast Cancer Screening, Breast Cancer Awareness
Not yet recruiting
The AYA Oncology Self-care Movement
Acute Lymphobkastic Leukemia, Medication Adherence
Not yet recruitingPhase 1/2
177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
Thyroid Cancer
RecruitingPhase 2
The COSMYC Trial (COmbined Suppression of MYC)
Metastatic Castration-resistant Prostate Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Danielle Friedman, MD principal investigator
Memorial Sloan Kettering Cancer Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cancer, run by Memorial Sloan Kettering Cancer Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 24 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Danielle Friedman, MD (212-639-7376, FriedmaD@mskcc.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Mean overall scores of Making Cents of Medical Costs (MCMC) (time frame: 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Aug 2026; AzTrials last refreshed its copy on 31 Oct 2026.